Gabify Raises $175K Pre-Seed Funding to Expand AI Neurodevelopmental Care

The company has also received ₹25 lakh under the Nidhi Seed Support Scheme from GHRTBI, a government-backed incubator supporting early-stage startups.

Gabify, an AI-driven HealthTech startup focused on neurodevelopmental care, has raised $175,000 in a pre-seed funding round led by Inflection Point Ventures (IPV). The company has also received INR 25 lakh under the Nidhi Seed Support Scheme from GHRTBI, a government-backed incubator supporting early-stage startups.

The funding will be deployed across clinical validation, technology enhancement, and team expansion as Gabify aims to scale its AI-based platform for early screening and therapy management of speech and neurodevelopmental disorders.

Founded in 2023, Gabify offers a SaaS-based ecosystem designed to support early diagnosis and intervention for conditions such as autism and ADHD. Its platform integrates dual AI capabilities—voice and vision—to assess speech patterns, facial expressions, eye gaze, and behavioral markers using over 189 clinically validated parameters aligned with DSM-5 and CARS standards. The system incorporates a human-in-the-loop model to validate AI-generated clinical outputs.

The platform has been tested across more than 35 preschool and daycare centers in India during its private beta phase. It is currently being adopted by schools, hospitals, private practices, and non-profit organizations. Gabify claims its technology can reduce assessment time by up to 70%, enabling clinicians to handle higher patient volumes without compromising accuracy.

The startup is part of IPV IdeaSchool’s fourth cohort, an incubation program supporting early-stage ventures. Inflection Point Ventures has invested over INR 1,200 crore across more than 280 startups and backed 18 companies in the fourth quarter of 2025.

Gabify’s platform is designed for scalability across diverse settings, including low-bandwidth and multilingual environments, with a focus on expanding access in underserved regions. The company is targeting impact across one million children by 2028 through a mix of B2B, B2C, and CSR-led deployments.

The global market for neurodevelopmental and assistive care technologies is estimated at $110 billion, driven by the rising prevalence of developmental disorders, increasing adoption of AI in healthcare, and a shortage of trained therapists.

Stay tuned for more such updates on Digital Health News